"162394-19-6"@en . . "Kepivance binds to the human keratinocyte growth factor (KGF) receptor found on buccal cell surfaces. The binding activates a Ras-MapK (Map kinase) signaling pathway which leads to the transcriptional activation of many proteins important for cell growth and survival."@en . "For treatment of oral mucositis associated with chemotherapy and radiation therapy."@en . . . . . . . "approved"@en . . "Fibroblast growth factor- 7"@en . "Elimination half-life: 4.5 hours (range: 3.3-5.7 hours)"@en . . . . " "@en . . . . . "KGF"@en . "Palifermin"@en . . "Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli."@en . . "HBGF-7"@en . . "FGF-7"@en . . "#Lexicomp [Internet]. Palifermin. 2014 [cited 1 December 2014]. Available from: http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7429#f_interactions"@en . . . . . . "Keratinocyte growth factor precursor"@en . "Humans and other mammals"@en .